Search

Your search keyword '"Read, Phillip"' showing total 387 results

Search Constraints

Start Over You searched for: Author "Read, Phillip" Remove constraint Author: "Read, Phillip"
387 results on '"Read, Phillip"'

Search Results

1. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot

2. Syphilis testing, incidence, and reinfection among gay and bisexual men in Australia over a decade spanning HIV PrEP implementation: an analysis of surveillance data from 2012 to 2022

3. Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis

4. Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs

6. Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study

7. Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

8. Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

9. Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study

11. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study

12. Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014–2023).

13. Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

14. Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study

15. Critical Success Factors for Intersectoral Collaboration: Homelessness and COVID-19 – Case Studies and Learnings from an Australian City

17. Chlamydia retesting remains low among young women in Australia: an observational study using sentinel surveillance data, 2018–2022

18. Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia.

21. Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

22. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

23. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

25. Health-related quality of life of people who inject drugs: The ETHOS Engage Study

26. Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study

28. Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.

30. Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

32. Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C)

34. Infectious syphilis in women and heterosexual men in major Australian cities: sentinel surveillance data, 2011–2019

35. Patient reported outcomes during and following HCV direct-acting antiviral treatment among people who inject drugs

36. Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study

37. How Australia and Aotearoa New Zealand avoided large‐scale mpox (formerly monkeypox) outbreaks in 2022–2023.

39. Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study

47. Syphilis: If you don't look for it, you'll miss it.

49. Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort

50. Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study

Catalog

Books, media, physical & digital resources